Metabolic Engineering

Overview

Definition and Scope

is defined as the science of rewiring the of cells to enhance the production of native metabolites or to enable cells to produce new products. This field encompasses a wide range of applications, including the generation of fuels, chemicals, foods, feeds, and pharmaceuticals, thereby significantly impacting various industries such as chemical, agriculture, food, pharmaceutical, and energy sectors.

Since its inception over 30 years ago, metabolic engineering has rapidly evolved through its integration with , , and , which has greatly advanced the industry. The discipline aims to improve the production of economically valuable molecules through manipulation of microbial metabolism, facilitating industrial-level molecule production.

Recent advancements in metabolic engineering (ME) have significantly contributed to the of chemicals, health, and environmental improvements, as summarized by a research team from KAIST, which reviewed the field's 30-year . This review highlights various examples of ME's progress and its contributions to addressing , including , , and food and energy shortages. The findings indicate that metabolic engineering plays a crucial role in the development of bio-based sustainable chemicals, , and , positioning it as a key solution to pressing issues faced by aging societies. Furthermore, the research discusses future challenges and perspectives, emphasizing that metabolic engineering will continue to be vital in promoting sustainability and addressing health challenges in the coming years.

Moreover, systems metabolic engineering (SysME) has emerged as an enabling that optimizes cellular performance to produce with higher titres, , and yields. This approach aligns with the United Nations' (SDGs), which advocate for towards and improving the while protecting the environment.

Key Principles and Techniques

Metabolic engineering is a multidisciplinary field that combines principles from systems biology, synthetic biology, and traditional metabolic engineering to enhance the production of , chemicals, and . This integration has led to significant advancements in the development of , which are engineered organisms capable of efficiently converting renewable resources into valuable products.

Recent advancements in systems metabolic engineering have significantly enhanced the development of industrially competitive strains by integrating systems biology, synthetic biology, and evolutionary with traditional metabolic engineering. This integration has expedited the creation of highly productive microbial cell factories, exemplified by early efforts to develop Escherichia coli strains capable of overproducing l-valine and l-threonine within a decade. Furthermore, recent tools and have been employed for , genetic module, pathway, flux, genome, and cell-level engineering, which are supported by illustrative examples. Notably, systems biology tools such as genome-scale (GEMs), along with machine learning-assisted pathway and deep learning-based enzyme design, have been developed to provide a comprehensive understanding of cellular systems and facilitate accurate predictions, thereby enhancing the potential of systems metabolic engineering.

Metabolic engineering is increasingly recognized for its potential to address global challenges such as climate change and environmental pollution. The exacerbation of climate change and has underscored the urgent need to replace with and sources. Metabolic engineering provides innovative strategies to engineer diverse organisms for the production of biofuels from renewable sources, thereby facilitating a transition away from dependency. Additionally, concerns regarding future oil supplies and climate change are driving interest in sustainable alternative sources of energy and chemicals, with biomass emerging as a renewable feedstock capable of replacing a significant fraction of petroleum used today. Furthermore, metabolic engineering plays a critical role in bioremediation by harnessing the metabolic activities of to degrade pollutants, thus contributing to environmental restoration. This approach is increasingly recognized as a cost-effective and environmentally friendly solution for cleaning up contaminated sites, including those affected by pesticides and . Emerging in metabolic engineering also offer precise methods for restoring to a fertile and contaminant-free state, highlighting its importance in .

The field of metabolic engineering is increasingly influential in the development of , particularly through the application of pharmacometabolomics. This evolving research area aims to achieve tailored therapeutic regimes by predicting and evaluating responses to based on individual metabolic fingerprints. The ability to correlate metabolic phenotypes into subgroups that exhibit different responses is becoming a reality through , which plays a crucial role in the advancement of personalized healthcare systems. Furthermore, the design of synthetic gene networks and prototype therapeutic circuits is expected to significantly impact future gene- and cell-based therapies, ushering in a new era of . These innovations may enable the development of personalized therapies that utilize synthetic genomes for specific drug synthesis and delivery, ultimately enhancing treatment for . As these principles and techniques continue to evolve, they demonstrate substantial potential to address both industrial and societal healthcare needs effectively.

History

Early Developments

The early developments in metabolic engineering marked significant milestones that laid the foundation for the field as it is known today. One of the pivotal achievements was the reconstruction of the Escherichia coli pathway for the conversion of the amino acid tryptophan into the plant-derived dye indigo, which represented a key milestone in metabolic engineering. This success was followed by several instances of engineering E. coli metabolism to overproduce various aromatic compounds, showcasing the potential of metabolic engineering to enhance microbial production capabilities.

Over the past three decades, metabolic engineering has rapidly evolved, benefiting from its integration with molecular biology, systems biology, and synthetic biology. This interdisciplinary approach has significantly advanced the biotechnology industry, enabling the production of high-value chemicals derived from both primary and . Notably, the development of methodologies such as flux analysis has allowed researchers to elucidate intracellular , further enhancing the understanding of .

A comprehensive review of the 30-year history of metabolic engineering highlights the contributions of this discipline to sustainability and health, emphasizing its role in producing bio-based sustainable chemicals and clean energy. Researchers have noted that metabolic engineering will increasingly address critical global challenges, including climate change, environmental pollution, and health issues associated with aging populations.

The early developments in metabolic engineering have prominently featured Escherichia coli, which is recognized as a veteran in industrial biotechnology. This organism has been utilized for groundbreaking applications, including the overproduction of the amino acid l-threonine and the first recombinant synthesis of human insulin, establishing E. coli as one of the best-studied microbes in the field. Multiple researchers have reported the use of to generate E. coli strains capable of accumulating various metabolic precursors, such as pyruvate, acetyl-CoA, malonyl-CoA, mevalonate, and shikimate, which provides a promising guideline for designing strains that can produce a variety of useful chemicals. Furthermore, both metabolic engineering and synthetic biology have made significant advances in biotechnology, contributing to the resolution of challenges in the production of pharmaceuticals, , and chemical compounds.

Evolution of Techniques

The evolution of techniques in metabolic engineering has been significantly influenced by advancements in synthetic biology and systems biology. Synthetic biology has emerged as a powerful discipline for creating novel biological systems, particularly in the subfield of and product engineering, which has facilitated the development of engineered organisms with optimized metabolic pathways. This integration of synthetic biology has led to smarter construct and higher yields of valuable chemicals, exemplified by the engineering of Saccharomyces cerevisiae to produce casbene, a diterpene precursor of many medically relevant terpenoids.

Recent advancements in systems metabolic engineering have further enhanced the capabilities of metabolic engineering by targeting various biological components of host cells. This approach has enabled the creation of highly productive microbial cell factories through the application of tools and strategies such as enzyme engineering, genetic , and genome-scale metabolic models (GEMs). These innovations have allowed for a more comprehensive understanding of cellular systems, leading to accurate predictions and improved designs for metabolic pathways.

The evolution of metabolic engineering has significantly advanced the production of biofuels, chemicals, and natural products, facilitating a transition from fossil-resource-dependent processes to sustainable bio-based methods. Over the past decade, advancements in metabolic engineering and synthetic biology have provided a range of tools and strategies for constructing efficient microbial cell factories, which are essential for this transition. Systems metabolic engineering, which integrates metabolic engineering with systems biology, synthetic biology, and evolutionary engineering, has revolutionized the sustainable production of fuels and materials through the creation of these efficient microbial cell factories. Recent developments in systems metabolic engineering have focused on targeting different biological components of host cells, enabling the creation of highly productive microbial cell factories. Furthermore, innovative tools such as genome-scale metabolic models and machine learning-assisted pathway design have been developed to enhance the potential of systems metabolic engineering by providing a comprehensive understanding of cellular systems and accurate predictions. These advancements underscore the critical role of metabolic engineering in addressing global challenges, including climate change and resource scarcity, by promoting sustainable production practices.

The evolution of plant metabolic engineering is increasingly recognized as a vital component in addressing global challenges such as climate change and . This field focuses on customizing to enhance , exemplified by efforts to increase iron content in crops, which can help combat . As technological capabilities advance, metabolic engineering is expected to expand the utility of plants beyond traditional sugar feedstocks, enabling the direct production of valuable compounds such as pharmaceuticals, renewable fuels, and commodity chemicals. Furthermore, the integration of engineered is being explored to improve , bioremediation, and the generation of renewable feedstocks, highlighting the potential for innovative strategies to enhance environmental sustainability. Overall, the development of novel metabolic pathways and the enhancement of production yields are crucial for creating sustainable solutions within the realm of metabolic pathway engineering.

Recent Advancements

Breakthroughs in Genetic Engineering

Recent advancements in metabolic engineering have led to significant breakthroughs in , particularly in the development of microbial cell factories. Systems metabolic engineering, which merges metabolic engineering with systems biology, synthetic biology, and evolutionary engineering, has transformed the sustainable production of fuels and materials by creating efficient microbial cell factories. This integration has facilitated the use of advanced tools and strategies, including genome-scale metabolic models (GEMs), (ML)-assisted pathway design, and (DL)-based enzyme design, which enhance the understanding of cellular systems and improve predictive capabilities.

The application of has emerged as a pivotal in high-throughput metabolic engineering, enabling the identification of novel genotype-phenotype relationships and the evolution of microbial cell factories for increased production of various chemicals, biofuels, and . Recent developments in engineering have yielded innovative tools for screening, driven by efforts in , , and rational re-engineering of (TFs) and riboswitches. These biosensors play crucial roles in optimizing microbial production strains through , adaptive laboratory evolution, and dynamic pathway control.

Moreover, the integration of metabolic circuits with TF-based biosensors has proven to be a robust solution for enhancing the production of target chemicals in engineered microbial strains. As many biosensors are still in the proof-of-concept stage, ongoing research is focused on their potential applications in metabolic engineering to accelerate the development of cell factories. New strategies have also been developed to balance metabolic flux within target pathways by tuning through the engineering of promoters, ribosome binding sites, and intergenic regions, allowing for simultaneous optimization of metabolic pathways while maintaining cellular .

Integration of Artificial Intelligence

The integration of (AI) and machine learning (ML) into metabolic engineering has significantly transformed the field, particularly in optimizing metabolic pathways and enhancing the efficiency of microbial cell factories. The increasing availability of bio , such as data, has facilitated the application of machine learning techniques across various stages of systems metabolic engineering, including host strain selection, metabolic pathway reconstruction, metabolic flux optimization, and fermentation processes.

are particularly valuable in identifying patterns within large datasets, which can lead to the development of more efficient microbial cell factories. These models enable the optimization of metabolic pathways by allowing for adjustments that enhance outputs while minimizing inputs. Traditional mathematical kinetic models, which have been used to predict pathway dynamics, are often time-consuming to develop and require significant biological expertise. In contrast, machine learning approaches can learn pathway dynamics directly from data examples, streamlining the modeling process.

Moreover, the application of machine learning extends to critical stages of metabolic engineering, such as process scale-up and . Here, ML-based methods can select optimal growth conditions and process parameters from extensive experimental datasets, ultimately maximizing titer, rate, and yield. The combination of mechanistic and machine learning models has also been proposed for predictive engineering, particularly in the optimization of specific metabolic processes, such as tryptophan metabolism.

As artificial intelligence (AI) technologies advance, they are projected to facilitate more accurate diagnoses and cost-effective treatments in various fields, including metabolic engineering. Machine learning (ML) and deep learning, both subsets of AI, play a crucial role in this evolution by enabling adjustments to metabolic pathways in living organisms, thereby optimizing outputs while minimizing inputs. Furthermore, AI and ML are revolutionizing metabolic engineering by enhancing the design of robust microbial strains and accelerating the development of sustainable bioproduction systems. This integration of AI technologies is expected to significantly improve the efficiency of microbial cell factories, ultimately leading to more effective metabolic engineering practices.

Applications

Biofuels and Chemicals Production

Metabolic engineering has significantly advanced the production of biofuels and chemicals, facilitating a transition from fossil fuel dependency to sustainable bio-based processes. This field focuses on the genetic manipulation of microbial metabolism to enhance the production of economically valuable molecules, which has been beneficial across various industries, including chemical, agriculture, food, pharmaceutical, and energy sectors.

Microbial cell factories, such as Saccharomyces cerevisiae and Aspergillus niger, have a long-standing history in natural fermentation processes for producing essential chemicals like ethanol and citric acid. Recent advancements in metabolic engineering have enabled the development of these microbial cell factories to efficiently produce biofuels and other chemicals, thereby supporting the creation of green and sustainable production methods.

To enhance chemical production through metabolic engineering, a variety of computational tools have been developed to identify genetic strategies for optimizing strain designs. These tools, including metabolic flux analysis and genome-scale metabolic models, are essential for predicting genetic modifications that can lead to increased yields of desired products. Recent advancements in systems metabolic engineering have focused on different biological components of the host cell, enabling the creation of highly productive microbial cell factories. Additionally, the integration of machine learning-assisted pathway design and deep learning-based enzyme design has significantly improved the capabilities of these systems biology tools, providing a comprehensive understanding of cellular systems and facilitating accurate predictions. Furthermore, the development of synthetic biology tools, such as /Cas9, along with novel concepts like dynamic control, has further advanced metabolic engineering efforts by allowing for more precise strain designs.

The ongoing research in metabolic engineering also emphasizes the utilization of carbon dioxide as a feedstock, which is crucial for developing sustainable bioproduction methods. This involves engineering endogenous CO2 fixation pathways and constructing novel synthetic pathways to improve CO2 assimilation efficiency. Overall, the application of metabolic engineering in biofuels and chemicals production not only enhances but also contributes to addressing environmental challenges associated with traditional fossil fuel processes.

Health and Pharmaceuticals

Metabolic engineering has gained recognition over the past decade as a valuable tool in the discovery and development of new natural-product drugs. This integration with traditional drug discovery processes offers significant advantages, particularly in the efficient and cost-effective production of various secondary metabolites with pharmacological value, derived from both plants and microorganisms. Furthermore, the goals of metabolic engineering, such as identifying genes that confer specific phenotypes, align conceptually and methodologically with central issues in drug discovery and . This synergy not only enhances the drug discovery process but also addresses critical challenges in the field.

Recent advancements in CRISPR-derived technologies have established these methods as the preferred choice for genome engineering in various organisms, particularly those relevant to industrial applications. The development of CRISPR technology has resolved several challenges associated with previous pathway engineering and genome editing techniques, allowing for the optimal construction of metabolic pathways that minimize negative effects while maximizing catalytic efficiency. As a result, the ambitious engineering aims of synthetic biology are rapidly becoming a reality, driven by improvements in genome editing and the identification and optimization of biosynthetic building blocks. These advancements are expected to significantly enhance the efficiency and of pharmaceutical compound production in the future.

Moreover, engineered microorganisms are increasingly being utilized as microbial cell factories to enhance the synthesis of chemical compounds, including natural products and antibiotics. This shift is driven by the limitations of wild-type strains, which often lack the metabolic capacity needed for efficient production. The application of synthetic biology tools in this context has shown promise in revitalizing discovery, particularly in the fight against multidrug-resistant (MDR) .

Challenges And Future Directions

Sustainability and Economic Viability

The integration of unconventional feedstocks and non-model organisms is increasingly recognized as a pivotal strategy for advancing sustainability in metabolic engineering. These unconventional feedstocks, such as hemicellulosic sugars and carbon dioxide, are gaining traction due to their potential to support advanced synthesis while minimizing environmental impact. The careful selection of substrate-organism-product combinations is essential for achieving environmentally and economically sustainable outcomes in metabolic engineering. This approach not only illuminates new avenues for but also enhances the diversity of products that can be synthesized.

approaches in metabolic engineering address critical challenges such as ineffective sequential , side reactions, and the untimely supply of cofactors, which can hinder production efficiency. These strategies have been explored for aggregating multiple enzymes within the same pathway, thereby improving sequential catalytic efficiency and enabling high-level production of desired products. To effectively tackle existing challenges in metabolic engineering, future strategies must account for all aspects of product synthesis, including the , translatome, proteome, and reactome. This comprehensive approach is essential for enhancing the performance and of assembly systems in metabolic engineering endeavors.

Synthetic biology has significantly advanced the development of strategies and has accelerated the creation of efficient microbial cell factories. Recent research highlights the integration of the glyoxylate shunt pathway into mammalian liver cells and mice, which has been explored for its effects on fatty acid metabolism and overall whole-body metabolism. This work exemplifies the potential of synthetic biology to address metabolic imbalances and enhance in engineered systems.

In the field of metabolic engineering, traditional model organisms such as Escherichia coli and Saccharomyces cerevisiae have been extensively utilized due to their advantageous characteristics, including low risks, rapid growth rates, and high tractability. However, these organisms exhibit limitations in their ability to biosynthesize certain carboxylic acid . Consequently, non-conventional like Yarrowia lipolytica and Kluyveromyces marxianus are emerging as promising alternatives for the production of value-added chemicals. Yarrowia lipolytica, in particular, is recognized for its potential as a valuable host for producing a diverse array of both and non-lipid chemical products, despite the challenges posed by its unique . Recent advances in metabolic engineering tools have facilitated improved genetic manipulation in this organism, enhancing its utility in various applications. The exploration of these non-conventional hosts is expanding the scope of metabolic engineering applications, with a focus on producing a variety of valuable chemicals, including fuels, cosmetics, and pharmaceuticals.

Regulatory and Ethical Considerations

Regulatory and ethical considerations in metabolic engineering are increasingly important as the field continues to evolve. Despite significant advancements, metabolic pathway engineering encounters several challenges, including pathway toxicity, metabolic imbalances, and limited knowledge of complex . Addressing these challenges is essential for ensuring the safety and efficacy of applications in this area. Future efforts will focus on implementing advanced computational tools, exploring non-conventional organisms, and enhancing the understanding of these .

Metabolic pathway engineering has made significant strides; however, it continues to face challenges such as pathway toxicity, metabolic imbalances, and a limited understanding of complex cellular networks. To address these issues, advanced computational tools, including metabolic flux analysis and genome-scale metabolic models, have been developed to predict genetic modifications that enhance chemical production. Additionally, self-assembly approaches have been employed to tackle problems like ineffective sequential catalysis, side reactions, and the untimely supply of cofactors. The integration of synthetic biology tools, such as CRISPR/Cas9, along with novel concepts like dynamic control and cell-free metabolic engineering, has further advanced metabolic engineering efforts. Future directions will likely focus on exploring non-conventional organisms and improving our understanding of metabolic pathways to overcome existing challenges.

As the field continues to evolve, addressing these regulatory and ethical challenges will be essential to foster public and ensure responsible innovation in metabolic engineering practices.

Tools And Methodologies

Synthetic Biology Tools

Synthetic biology tools have significantly advanced the field of metabolic engineering, enabling the precise manipulation of microbial metabolism for various applications. One of the most notable advancements is the development of the CRISPR-Cas9 system, which has revolutionized genetic editing by allowing for targeted modifications in microbial genomes. This tool is particularly valued for its precision and efficiency, facilitating significant improvements in microbial functions and applications across multiple domains, including agriculture and pharmaceuticals.

In recent years, significant advancements in synthetic biology have been achieved through the development of various computational tools aimed at enhancing strain design and predicting genetic modifications for improved chemical production. Among these tools are metabolic flux analysis, genome-scale metabolic models (GEMs), and algorithms such as OptKnock, which collectively facilitate the identification of optimal genetic designs for metabolic engineering. GEMs, in particular, are powerful tools that enable the mathematical simulation of metabolism across archaea, , and eukaryotic organisms. They quantitatively define the relationship between genotype and phenotype by integrating diverse types of Big Data, including , metabolomics, and transcriptomics. Furthermore, there have been numerous metabolic engineering efforts focused on developing engineered strains of Yarrowia lipolytica with enhanced lipid yields, showcasing the practical applications of these computational tools in real-world scenarios.

Moreover, advanced mass metabolomics methods, including isotope flux analysis and untargeted metabolomics, are employed to characterize metabolic pathways and guide the engineering of synthetic bioproduction pathways. These methods have shown great potential in developing metabolomics-directed synthetic bioproduction, further enhancing the capabilities of metabolic engineering.

Case Studies

Successful Microbial Cell Factories

Successful microbial cell factories are a cornerstone of metabolic engineering, enabling the industrial-scale production of valuable chemicals from renewable resources. A prominent example is the collaboration between DuPont and Tate & Lyle, which has advanced from a pilot fermentation process to constructing a plant with a 100,000-ton annual capacity for feedstock chemicals production. This illustrates the practical application of metabolic engineering in developing efficient microbial strains for high-yield production.

Over recent decades, numerous case studies have documented the successful production of microbially derived chemicals at various scales, categorized as industrial (greater than 50 g/L), medium (5-50 g/L), and lab scale (0-5 g/L). These studies underscore the versatility of engineered microorganisms in chemical synthesis. Systems metabolic engineering has been pivotal in developing high-performance strains for producing a diverse range of bioproducts, including bulk and fine chemicals, polymers, biofuels, and natural products.

The engineering of microorganisms focuses on enhancing the synthesis of chemical compounds, as wild-type strains often lack the necessary metabolic capacity. This has led to the development of tools and strategies to optimize metabolic pathways, crucial for bio-based production of natural products like drugs, nutraceuticals, and pigments. Key techniques include pathway manipulation methods such as gene overexpression, silencing, and knockouts to improve target metabolite yields.

To further improve microbial cell factory efficiency, computational tools like metabolic flux analysis and genome-scale metabolic models have been developed to predict genetic modifications that enhance chemical production. Additionally, advancements in synthetic biology, including CRISPR/Cas9 technology and dynamic control systems, have significantly contributed to precise microbial strain engineering.

Innovations in Organic Acid Production

DuPont Tate & Lyle Bio Products has made significant strides in the field of metabolic engineering, particularly in the production of organic acids such as 1,3-propanediol (1,3-PDO). This joint venture was the first to achieve production at a scale of thousands of metric tons per year using a metabolically engineered host, with commercial production of 1,3-PDO from corn starch commencing in 2006. Nearly a decade later, the company reported ongoing progress in expanding production capabilities, demonstrating the potential for large-scale industrial applications of metabolic engineering.

Recent advancements in cell-free metabolic engineering have shown significant progress, including the development of pathways that extend beyond eight enzyme steps, achieving near theoretical mass yields, and demonstrating volumetric productivities of several grams per liter per hour, with successful scale-up into hundreds of liters. The enzymatic hydrolysis process has been effectively scaled up and utilized in industrial-scale plants operated by Beta Renewables, while DuPont Tate & Lyle Bio Products has produced microbial 1,3-propanediol (1,3-PDO) from corn-derived sugars since 2006, achieving an annual production of approximately 63,500 kilotonnes. This illustrates the practical applications of metabolic engineering in the industrial production of organic acids, as well as the ongoing challenges in scaling these innovative processes, which include the need for new technologies to enable metabolic engineering to be scaled up to the industrial level.

Recent advancements in metabolic engineering and synthetic biology have provided a range of tools and strategies for constructing efficient microbial cell factories, significantly enhancing the sustainable production of organic acids and other bioproducts. Systems metabolic engineering, which integrates metabolic engineering with systems biology, synthetic biology, and evolutionary engineering, has revolutionized this field by enabling the creation of highly productive microbial cell factories tailored for industrial applications. However, many engineered strains encounter challenges such as redox imbalance and excess metabolic burden, which can lead to poor product yields. To address these issues, significant developments have been made in the co-cultivation of multiple engineered strains, allowing for the distribution of metabolic burdens and ultimately improving product yields. Furthermore, addressing these imbalances to enhance target pathway flux represents a major challenge for metabolic engineers, who traditionally identify and remove bottlenecks in pathway design through sequential optimization campaigns.

References

1

PDF

phys.org

13

PDF

cell.com

78

PDF

longdom.org

139

PDF

zhaogroup.chbe.illinois.edu

183

PDF

longdom.org

185

PDF

zhaogroup.chbe.illinois.edu

225

PDF

zhaogroup.chbe.illinois.edu

272

PDF

zhaogroup.chbe.illinois.edu